Peritoneal dialysis in diabetics: there is room for more
- PMID: 22013524
- PMCID: PMC3195540
- DOI: 10.4061/2011/914849
Peritoneal dialysis in diabetics: there is room for more
Abstract
End stage renal disease diabetic patients suffer from worse clinical outcomes under dialysis-independently of modality. Peritoneal dialysis offers them the advantages of home therapy while sparing their frail vascular capital and preserving residual renal function. Other benefits and potential risks deserve discussion. Predialysis intervention with early nephrology referral, patient education, and multidisciplinary support are recommended. Skilled and updated peritoneal dialysis protocols must be prescribed to assure better survival. Optimized volume control, glucose-sparing peritoneal dialysis regimens, and elective use of icodextrin are key therapy strategies. Nutritional evaluation and support, preferential use of low-glucose degradation products solutions, and prescription of renin-angiotensin-aldosterone system acting drugs should also be part of the panel to improve diabetic care under peritoneal dialysis.
Similar articles
-
Predialysis glycemic control is an independent predictor of clinical outcome in type II diabetics on continuous ambulatory peritoneal dialysis.Perit Dial Int. 1997 May-Jun;17(3):262-8. Perit Dial Int. 1997. PMID: 9237287
-
Low GDP Solution and Glucose-Sparing Strategies for Peritoneal Dialysis.Semin Nephrol. 2017 Jan;37(1):30-42. doi: 10.1016/j.semnephrol.2016.10.005. Semin Nephrol. 2017. PMID: 28153193 Review.
-
Cost benefits of peritoneal dialysis in specific groups of patients.Contrib Nephrol. 2009;163:285-291. doi: 10.1159/000223812. Epub 2009 Jun 3. Contrib Nephrol. 2009. PMID: 19494627
-
Predictors of Residual Renal Function Decline in Peritoneal Dialysis Patients: The balANZ Trial.Perit Dial Int. 2017 May-Jun;37(3):283-289. doi: 10.3747/pdi.2016.00206. Epub 2016 Dec 1. Perit Dial Int. 2017. PMID: 27935537 Clinical Trial.
-
Diabetes mellitus and dialysis.Minerva Urol Nefrol. 2004 Sep;56(3):289-303. Minerva Urol Nefrol. 2004. PMID: 15467507 Review.
Cited by
-
Challenges of Glycemic Control in People With Diabetes and Advanced Kidney Disease and the Potential of Automated Insulin Delivery.J Diabetes Sci Technol. 2024 Nov;18(6):1500-1508. doi: 10.1177/19322968231174040. Epub 2023 May 10. J Diabetes Sci Technol. 2024. PMID: 37162092 Free PMC article. Review.
-
[Peritoneal dialysis--an ideal initial dialysis mode].Wien Med Wochenschr. 2013 Jun;163(11-12):271-9. doi: 10.1007/s10354-013-0200-x. Epub 2013 Jul 2. Wien Med Wochenschr. 2013. PMID: 23817731 Review. German.
-
Renal Replacement Therapy: Purifying Efficiency of Automated Peritoneal Dialysis in Diabetic versus Non-Diabetic Patients.J Clin Med. 2015 Jul 22;4(7):1518-35. doi: 10.3390/jcm4071518. J Clin Med. 2015. PMID: 26239689 Free PMC article.
-
Transitioning to peritoneal dialysis: it does not matter where you come from.J Bras Nefrol. 2024 Jul-Sep;46(3):e20230139. doi: 10.1590/2175-8239-JBN-2023-0139en. J Bras Nefrol. 2024. PMID: 38717919 Free PMC article.
-
Clinical outcomes of infection-related hospitalization in incident peritoneal dialysis patients.Kidney Res Clin Pract. 2020 Dec 31;39(4):460-468. doi: 10.23876/j.krcp.20.069. Kidney Res Clin Pract. 2020. PMID: 33184240 Free PMC article.
References
-
- Foley RN. Temporal trends in the burden of chronic kidney disease in the United States. Current Opinion in Nephrology and Hypertension. 2010;19(3):273–277. - PubMed
-
- Meyer TW, Hostetter TH. Medical progress: uremia. The New England Journal of Medicine. 2007;357(13):1316–1325. - PubMed
-
- U.S. Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in United States. Bethesda, Md, USA: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010.
LinkOut - more resources
Full Text Sources